After years of hosting long-form conversations with physicians, researchers, journalists, and filmmakers about the state of women’s health, a pattern became increasingly difficult to ignore. The primary barrier to innovation was not a lack of scientific research. It was the absence of shared standards for interpreting and applying that research as it moved across medicine, media, and investment.
That realization now underpins the launch of Khora, a new initiative focused on accelerating women’s health innovation by confronting the funding gaps that have historically slowed progress in the field.
The Hormonal Podcast was created as a space for evidence-driven conversations at the intersection of medicine, culture, and public discourse. From its inception, the podcast brought together an interdisciplinary group of guests: practicing physicians and reproductive health researchers alongside journalists and filmmakers whose work has shaped public understanding of women’s health.
Among those voices are clinicians and scholars such as Dr. Randi Hutter Epstein and Dr. Rene Almeling, as well as Academy Award–winning filmmaker Melissa Berton and cultural storytellers like Rico Herre, producer of Impure. Across disciplines, the podcast examines how evidence on women’s health is produced, interpreted, and communicated, and critically, where those processes break down.
What emerged from these conversations was not merely a cultural issue, but an investment one.
Clinicians consistently expressed frustration with how scientific rigor becomes flattened in public narratives. Nuance is lost as research is translated into headlines, advocacy campaigns, or consumer messaging. At the same time, founders and investors described difficulty interpreting complex medical data within decision-making environments that are not designed to accommodate scientific uncertainty, methodological variation, or longitudinal outcomes.
The result is a paradox. Women’s health research has long been delayed and underdeveloped, but even the evidence that exists has been inconsistently evaluated and poorly translated. The gap is not only scientific, but structural: a lack of shared standards to carry rigor from the clinic into media narratives and investment decisions. This disconnect has consequences. When evidence is oversimplified or inconsistently evaluated, high-quality women’s health innovations struggle to secure funding, while less rigorous solutions can scale more easily. Capital is not just under-allocated, it is frequently misallocated.
The podcast’s creator, Zarah Khondoker, has become a prominent voice in reframing how society discusses women’s reproductive health. A two-time TEDx speaker, Khondoker’s talks — “The Power of Being ‘Hormonal’” and “A New Period of Time: Why Menstruation Is the Future of Women’s Health Missing Data” — explore how biological realities have been historically dismissed through language rather than understood through evidence.
“At every point of a woman’s life — from our periods, to pregnancy, and even menopause — the word ‘hormonal’ has been used against us,” Khondoker has said. “We must reclaim the word hormonal, because it is often used to diminish women instead of informing our reproductive health.”
That reframing reflects a core principle of the podcast itself. Despite featuring guests from diverse professional backgrounds — including filmmakers, activists, professors, physicians, researchers, and journalists — each episode maintains a consistent commitment to evidence-driven discussion. The long-form format allows for scientific context, historical framing, and nuance that is often lost in short-form or trend-based women’s health media.
Importantly, the podcast treats lived experience as data rather than anecdote, grounding personal stories within broader scientific, sociological, or historical frameworks. Personal narratives inform understanding, but do not replace rigor.
Another distinguishing feature of the podcast is its examination of how clinical evidence moves beyond academic settings into media, activism, and everyday understanding. Episodes explore where translation can become distorted, oversimplified, or politicized — and what is lost when it does.
The transition from podcast to investment initiative reflects insights gained from these conversations. Women’s reproductive health has historically been both under-researched and under-funded, despite women comprising half the global population. Even as stigma has slowly loosened its grip on public discussion, innovation continues to face structural barriers to capital.
Khora is positioned as a response to that reality. Its mission is to ensure that women’s health innovation does not bear the same cost that stigma once imposed on conversation. Where the podcast diagnosed failures in how evidence is communicated, Khora aims to intervene in how that evidence is evaluated, trusted, and funded.
The audience cultivated through The Hormonal Podcast spans graduate students and early-career professionals, clinicians and researchers, journalists and filmmakers, activists and reproductive justice advocates, and founders and investors working in women’s health. Together, these conversations point to a single conclusion: meaningful progress in women’s health requires not just more research, but better systems for translating evidence into action.
By building on years of evidence-driven dialogue, the move from podcast to platform represents an evolution from diagnosis to intervention, applying lessons learned from examining how women’s health evidence is produced and communicated to the question of how it is financed and scaled.
